Bar Harbor Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.8M Sell
65,715
-4,790
-7% -$4.89M 4.23% 3
2026
Q1
$64.8M Sell
70,505
-1,605
-2% -$1.63M 3.79% 4
2025
Q4
$77.5M Sell
72,110
-217
-0.3% -$207K 4.48% 2
2025
Q3
$55.2M Sell
72,327
-2,647
-4% -$1.97M 3.31% 5
2025
Q2
$58.4M Sell
74,974
-1,139
-1% -$885K 3.74% 4
2025
Q1
$62.9M Sell
76,113
-835
-1% -$695K 4.16% 2
2024
Q4
$59.4M Sell
76,948
-340
-0.4% -$282K 3.89% 4
2024
Q3
$68.5M Sell
77,288
-709
-0.9% -$637K 4.37% 2
2024
Q2
$70.6M Sell
77,997
-151
-0.2% -$121K 4.67% 2
2024
Q1
$60.8M Sell
78,148
-715
-0.9% -$509K 4.06% 2
2023
Q4
$46M Sell
78,863
-697
-0.9% -$407K 3.43% 4
2023
Q3
$42.7M Sell
79,560
-950
-1% -$490K 3.4% 4
2023
Q2
$37.8M Sell
80,510
-370
-0.5% -$155K 2.9% 6
2023
Q1
$27.8M Sell
80,880
-221
-0.3% -$74.5K 2.21% 6
2022
Q4
$29.7M Sell
81,101
-27
-0% -$9.57K 2.37% 7
2022
Q3
$26.2M Sell
81,128
-548
-0.7% -$174K 2.26% 7
2022
Q2
$26.5M Buy
81,676
+2,246
+3% +$674K 2.12% 8
2022
Q1
$22.7M Sell
79,430
-616
-0.8% -$159K 2.04% 10
2021
Q4
$22.1M Sell
80,046
-3,705
-4% -$939K 1.88% 12
2021
Q3
$19.4M Sell
83,751
-517
-0.6% -$128K 1.81% 11
2021
Q2
$19.3M Sell
84,268
-460
-0.5% -$92.4K 1.8% 11
2021
Q1
$15.8M Sell
84,728
-1,056
-1% -$207K 1.54% 14
2020
Q4
$14.5M Buy
85,784
+50
+0.1% +$7.46K 1.45% 14
2020
Q3
$12.7M Sell
85,734
-555
-0.6% -$85.9K 1.4% 15
2020
Q2
$14.2M Sell
86,289
-2,569
-3% -$394K 1.64% 12
2020
Q1
$12.3M Sell
88,858
-791
-0.9% -$109K 1.66% 12
2019
Q4
$11.8M Sell
89,649
-1,863
-2% -$216K 1.29% 20
2019
Q3
$10.2M Sell
91,512
-270
-0.3% -$30.1K 1.19% 24
2019
Q2
$10.2M Buy
91,782
+507
+0.6% +$59.7K 1.18% 24
2019
Q1
$11.8M Sell
91,275
-74
-0.1% -$9K 1.42% 19
2018
Q4
$10.6M Sell
91,349
-370
-0.4% -$41.3K 1.41% 22
2018
Q3
$9.84M Sell
91,719
-487
-0.5% -$48.7K 1.12% 28
2018
Q2
$7.87M Sell
92,206
-308
-0.3% -$25.3K 0.95% 31
2018
Q1
$7.16M Sell
92,514
-690
-0.7% -$55.5K 0.88% 32
2017
Q4
$7.87M Sell
93,204
-510
-0.5% -$43.4K 0.92% 31
2017
Q3
$8.02M Sell
93,714
-446
-0.5% -$36.6K 0.97% 31
2017
Q2
$7.75M Sell
94,160
-2,398
-2% -$196K 0.93% 32
2017
Q1
$8.12M Sell
96,558
-1,279
-1% -$102K 0.95% 30
2016
Q4
$7.2M Sell
97,837
-792
-0.8% -$59K 0.79% 34
2016
Q3
$7.92M Buy
98,629
+37
+0% +$2.96K 0.9% 31
2016
Q2
$7.76M Sell
98,592
-1,370
-1% -$103K 0.9% 30
2016
Q1
$7.2M Sell
99,962
-4,167
-4% -$315K 0.88% 31
2015
Q4
$8.77M Sell
104,129
-73
-0.1% -$6.06K 1.1% 26
2015
Q3
$8.72M Sell
104,202
-1,443
-1% -$122K 1.16% 25
2015
Q2
$8.82M Buy
105,645
+2,628
+3% +$200K 1.07% 27
2015
Q1
$7.48M Sell
103,017
-200
-0.2% -$14.2K 0.91% 31
2014
Q4
$7.12M Sell
103,217
-305
-0.3% -$20.6K 0.89% 32
2014
Q3
$6.71M Sell
103,522
-901
-0.9% -$57K 0.86% 32
2014
Q2
$6.49M Sell
104,423
-334
-0.3% -$19.9K 0.81% 38
2014
Q1
$6.17M Sell
104,757
-357
-0.3% -$19.9K 0.79% 36
2013
Q4
$5.36M Sell
105,114
-545
-0.5% -$27.3K 0.7% 42
2013
Q3
$5.32M Sell
105,659
-364
-0.3% -$19.1K 0.75% 39
2013
Q2
$5.21M Buy
+106,023
New +$5.77M 0.75% 36

Other funds holding LLY

Bar Harbor Wealth Management's LLY Position: Q2 2026 in Review

Bar Harbor Wealth Management reduced its Eli Lilly (LLY) stake by 6.8% in Q2 2026, selling an estimated $4.89M and leaving 65,715 shares worth $78.8M. The position accounts for 4.23% of the portfolio, ranked #3.

Bar Harbor Wealth Management first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bar Harbor Wealth Management held 65,715 shares of Eli Lilly worth $78.8M as of Q2 2026.
  • Bar Harbor Wealth Management sold 4,790 Eli Lilly shares in Q2 2026, an estimated $4.89M.
  • Eli Lilly made up 4.23% of Bar Harbor Wealth Management's portfolio in Q2 2026, its #3 holding.
  • Bar Harbor Wealth Management first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bar Harbor Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.